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Abstract: The hypothalamic paraventricular nucleus (PVN) regulates 
numerous homeostatic systems and functions largely under the influence of 
forebrain inputs. Glutamate is a major neurotransmitter in forebrain, and 
glutamate neurosignaling in the PVN is known to mediate many of its 
functions. Previous work showed that vesicular glutamate transporters 
(VGluTs; specific markers for glutamatergic neurons) are expressed in 
forebrain sites that project to the PVN; however, the extent of this presumed 
glutamatergic innervation to the PVN is not clear. In the present study 
retrograde FluoroGold (FG) labeling of PVN-projecting neurons was combined 
with in situ hybridization for VGluT1 and VGluT2 mRNAs to identify forebrain 
regions that provide glutamatergic innervation to the PVN and its immediate 
surround in rats, with special consideration for the sources to the anterior 
versus posterior PVN. VGluT1 mRNA colocalization with retrogradely labeled 
FG neurons was sparse. 
VGluT2 mRNA colocalization with FG neurons was most abundant in 
the ventromedial hypothalamus after anterior PVN FG injections, and in the 
lateral, posterior, dorsomedial, and ventromedial hypothalamic nuclei after 
posterior PVN injections. Anterograde tract tracing combined with VGluT2 
immunolabeling showed that 1) ventromedial nucleus-derived glutamatergic 
inputs occur in both the anterior and posterior PVN; 2) posterior nucleus-
derived glutamatergic inputs occur predominantly in the posterior PVN; and 
3) medial preoptic nucleus-derived inputs to the PVN are not glutamatergic, 
thereby corroborating the innervation pattern seen with retrograde tracing. 
The results suggest that PVN subregions are influenced by varying amounts 
and sources of forebrain glutamatergic regulation, consistent with functional 
differentiation of glutamate projections. 
INDEXING TERMS: vesicular glutamate transporter, FluoroGold, retrograde 
labeling, Phaseolus vulgaris leucoagglutinin, anterograde labeling 
The paraventricular nucleus of the hypothalamus (PVN) plays a 
role in regulating body temperature, sexual function, lactation, food 
intake, energy balance, water/osmotic balance, and the activities of 
the hypothalamic–pituitary–adrenocortical axis and the autonomic 
nervous system (Bisset and Chowdrey, 1988; McKenna, 2001; Nagy et 
al., 2005; Schlenker, 2005). The PVN is under the control of 
forebrain/limbic inputs (Herman et al., 2003; Fehm et al., 2006; 
Lechan and Fekete, 2006), many of which use glutamate as the 
principal excitatory neurotransmitter. The PVN is heavily innervated by 
glutamatergic fibers (van den Pol, 1991; Wittmann et al., 2005; 
Ziegler et al., 2005) and PVN neurons express several types of 
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glutamate receptors (Aubry et al., 1996; Mateos et al., 1998; Herman 
et al., 2000; Eyigor et al., 2005; Ziegler et al., 2005), suggesting that 
glutamate is an important neurotransmitter in this region. A prominent 
role for glutamate signaling in the PVN is supported by studies 
indicating excitatory effects of glutamate on hypothalamic–pituitary–
adrenocortical axis activity (Ziegler and Herman, 2000), sympathetic 
tone (Badoer et al., 2003; Freeman and Brooks, 2007), sexual 
behavior (Melis et al., 2004), suckling-induced prolactin release (Nagy 
et al., 2005), and food intake (Hettes et al., 2003). Collectively, this 
work suggests that glutamatergic inputs from the forebrain are critical 
regulators of PVN functions. 
The specific forebrain origins of glutamatergic innervation to the 
PVN are not clear. Interpretation of previous work addressing this 
question is made difficult by the paucity of specific markers for 
glutamatergic neurons (e.g., all cells contain some glutamate as a part 
of normal cellular metabolism). Definitive identification of glutamate 
neurons has only become possible with the recent cloning of vesicular 
glutamate transporters, which specifically package glutamate into 
synaptic vesicles. 
Therefore, the present work combines tract tracing with 
phenotypic markers of glutamate neurons to determine glutamate 
inputs to the PVN. The retrograde tracing approach uses expression of 
vesicular glutamate transporter 1 (VGluT1) and 2 (VGluT2) mRNAs as 
specific markers of glutamatergic neurons (reviewed in Ziegler et al., 
2002; Takamori, 2006) combined with retrograde FluoroGold (FG) 
labeling of PVN-projecting neurons to identify forebrain regions that 
provide glutamatergic innervation to the PVN and its surround, with 
special consideration for the sources of innervation to the anterior 
versus posterior PVN. Given the paucity of VGluT1 mRNA expression in 
forebrain regions that project directly to the PVN (Kaneko and 
Fujiyama, 2002; Ziegler et al., 2002; Collin et al., 2003), we 
hypothesized that PVN-projecting glutamatergic neurons would be 
characterized primarily by the expression of VGluT2 mRNA. Moreover, 
we hypothesized that established PVN-projecting forebrain sites with 
known expression of VGluT2 mRNA (Ziegler et al., 2002; Collin et al., 
2003; Lin et al., 2003), such as the ventromedial hypothalamic 
nucleus, dorsomedial hypothalamic nucleus, lateral hypothalamic area, 
and posterior hypothalamus nucleus, would be the primary sources of 
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glutamatergic innervation to the PVN. In addition, to corroborate 
projections identified by retrograde tracing studies, anterograde 
tracing with Phaseolus vulgaris leucoagglutinin (PhaL) was combined 
with immunolabeling for VGluT2 to determine the extent to which 
various regions provide glutamatergic inputs to the PVN. 
Materials and Methods 
Experimental animals 
Adult, male, Sprague–Dawley rats (250–350 g; Harlan, 
Indianapolis, IN) were used. Rats arrived at least 1 week prior to the 
onset of experiments and were housed on a 12-hour light/dark cycle 
(06:00–18:00) with ad libitum access to normal rat chow and water in 
a constant temperature-humidity vivarium. All procedures were 
approved by the University of Cincinnati Animal Care and Use 
Committee. 
FluoroGold injections 
Experiments used retrograde labeling of FG targeted to the PVN 
to identify PVN-projecting neurons. Rats were anesthetized 
(intraperitoneally [i.p.]) with a mixture of ketamine (95 mg/kg body 
weight) and xylazine (12.5 mg/ kg body weight) and then placed into 
a Kopf (Tujunga, CA) stereotaxic apparatus. Surgical procedures 
employed aseptic technique. FG (2% in saline vehicle; Fluorochrome, 
Denver, CO) was backfilled into a glass micropipette with a tip 
diameter of 10–15 µm. The micropipette was slowly inserted 
unilaterally into the PVN (from bregma AP −1.5 mm, ML −0.4 mm, 
and DV −6.65 mm from dura). FG was iontophoretically injected using 
an intermittent current (2–4 μA with 7 seconds on/off for ≈30 
seconds). The micropipette was then slowly raised, the skull hole was 
filled with bone wax, and the skin incision was wound-clipped. 
Following ≈7–10 days recovery, rats were given sodium 
pentobarbital overdose (150 mg/kg body weight) and perfused with 
4% paraformaldehyde in sodium phosphate-buffered saline (NaPBS, 
0.1 M, pH 7.4). The brains were removed and placed in vials with 4% 
paraformaldehyde in PBS overnight, followed by placement into 30% 
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sucrose at 4°C. Coronal microtome sections (25 µm thick) were cut 
through the brain, placed into cryoprotective solution (30% sucrose, 
w/v; 1% polyvinlypyrrolidone [PVP-40], w/v; 30% ethylene glycol, 
v/v; in 50 mM sodium phosphate buffer, pH 7.4), and were stored at 
−20°C until use. 
Preparation of vesicular glutamate transporter cRNA 
probes 
In situ hybridization for VGluT1 and VGluT2 mRNAs was used to 
specifically identify these two classes of glutamatergic neurons (Ziegler 
et al., 2002). Antisense cRNA probes complementary to VGluT1 
(1666–1976 bp of Access no. NM_053859.1) and VGluT2 (1972–2437 
bp of Access. no. NM_053427.1) were generated by in vitro 
transcription using 35S-UTP, as described previously (Ziegler et al., 
2002). The VGluT1 and VGluT2 fragments were each cloned into a 
pGEM-T Easy plasmid vector, linearized with PvuII (VGluT1) or StyI 
(VGluT2), and transcribed with T7 (VGluT1) or SP6 (VGluT2) RNA 
polymerases. 
In situ hybridization combined with FG 
immunocytochemistry 
Prior to hybridization, a 1-in-6 series of sections was washed 
with 50 mM NaPBS and incubated in blocking buffer (0.3% TX-100 and 
0.2% bovine serum albumin [BSA] in NaPBS). Sections were 
hybridized overnight at 45°C with 4.5 × 106 cpm 35S labeled probe/5 
mL/well, diluted in hybridization medium (50% formamide, 20 mM 
Tris-HCl, pH 7.5, 1 mM EDTA, 335 mM sodium chloride, 1 × 
Denhardt’s, 200 µg/mL salmon sperm DNA, 25 µg/ mL yeast tRNA, 20 
mM dithiothreitol, and 10% dextran sulfate). Tissue sections were then 
rinsed in 2× SSC buffer (1 × SSC = 0.25 M sodium chloride, 0.015 M 
sodium citrate, pH 7.2) and treated with RNAse A (200 µg/ mL) for 3 
hours at 37°C. Sections were washed in 2× SSC, 1× SSC, and 0.5 × 
SSC at room temperature and incubated for 1 hour at 45°C in 0.5× 
SSC. Following incubation in blocking buffer at room temperature, the 
sections were placed into primary antibody directed against FG 
(1:5,000 in blocking buffer; kindly provided by Dr. Stanley Watson, 
University of Michigan; Table 1) overnight at 4°C. The sections were 
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washed with 50 mM potassium phosphate buffered saline (KPBS), 
0.02% TX-100, and then incubated with affinity-purified biotinylated 
anti-rabbit immunoglobulin G (IgG) made in goat (1:500 in 50 mM 
KPBS, 0.02% TX-100; Vector Laboratories, Burlingame, CA). After 
incubation the sections were washed in 50 mM KPBS, 0.02% TX-100, 
and incubated in Vectastain ABC Solution (1:1,000 in 50 mM KPBS, 
0.1% BSA; Vector Laboratories). After incubation the sections were 
washed in 50 mM KPBS/0.02% TX-100 and visualized by exposure to 
3,3’-diaminobenzidine (DAB; 0.4 mg/mL in 50 mM KPBS/0.005% 
hydrogen peroxide). FG was visualized by chromagen reaction to 
provide a stable signal for detection of colocalization in emulsion-
dipped sections. Following rinsing the sections were mounted onto 
glass slides that were subsequently coated with Kodak photographic 
emulsion NTB2 (diluted 1:1 with water), air-dried, and stored at 4°C in 
a light- and humid-free environment for 4 weeks. Following 
development in Kodak D-19 developer and Rapid Fix solutions, 
emulsion-dipped sections were dehydrated through a series of graded 
ethanol, cleared with xylene, and coverslipped using DPX mountant 
(Fluka, Milwaukee, WI). 
  
PhaL injections and immunohistochemistry 
Iontophoretic injection of the anterograde tract tracer PhaL into 
the ventromedial, posterior, and medial preoptic hypothalamic nuclei, 
with subsequent visualization of boutons coimmunolabeled for PhaL 
and VGluT2 in the PVN, was employed to independently determine 
whether the PVN receives differential VGluT2-positive innervation from 
these regions along its rostral-caudal extent. Injections of PhaL (2.5% 
in 10 mM phosphate buffer, pH 8.0; Vector Laboratories) were 
performed as described above for FG with the following exceptions. 
First, the unilateral injections were targeted to either the ventromedial 
nucleus (from bregma AP −2.6 mm, ML 0.6 mm, and DV −9.0 to −9.4 
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mm from dura), the posterior nucleus (from bregma AP −3.8 mm, ML 
0.5 mm, and DV −7.3 to −7.7 mm from dura), or the medial preoptic 
nucleus (from bregma AP−0.8 mm, ML 0.45 mm, and DV −8.4 to −8.8 
mm from dura). Second, the micropipette tip had a diameter of 20–25 
µm and the PhaL was injected using a 5 μA intermittent current (7 
seconds on/off) for 15 minutes. 
Following 7–10 days recovery the rats were perfused and the 
brains were collected and sectioned as described above. For single 
immunolabeling of PhaL, tissue sections were rinsed in KPBS, 
incubated in 1% hydrogen peroxide (10 minutes), rinsed, and then 
incubated in blocking buffer (50 mM KPBS, 0.1% BSA, and 0.2% TX-
100) for 1 hour at room temperature. Sections were placed into goat 
anti-PhaL primary antibody (1:3,000 in blocking buffer; Vector 
Laboratories; product #AS-2224, lot #N0712) overnight at 4°C. 
Following incubation the sections were rinsed and placed into affinity-
purified biotinylated horse antigoat IgG (1:500 in 50 mM KPBS/0.01% 
BSA; Vector Laboratories) for 1 hour. Sections were rinsed again and 
placed into Vectastain ABC Solution (1:1,000 in 50 mM KPBS/0.1% 
BSA; Vector Laboratories) for 1 hour. After rinsing, sections were 
stained with DAB (as described above), rinsed, mounted onto slides, 
dehydrated through a graded series of ethanol, cleared with xylene, 
and coverslipped with DPX mountant. Dual immunolabeling of PhaL 
and VGluT2 was performed as described above, except 1) rabbit anti-
VGluT2 antibody (1:500; Synaptic Systems, Gottingen, Germany, 
product #135 402, lot 135402/12) was added to the anti-PhaL primary 
antibody incubation; and 2) immunolabeling was visualized using 
Alexa488-conjugated donkey antigoat IgG (1:500; Invitrogen, La Jolla, 
CA; product #A11055, lot 645148) and Cy3-conjugated affinity 
purified donkey antirabbit IgG (1:500; Jackson ImmunoResearch Labs, 
West Grove, PA; product #711-165-152, lot 88464). 
Antibody characterization 
The anti-FG primary antiserum was generated against the FG 
molecule. The efficacy of the FG antiserum was verified by dual 
fluorescence imaging, demonstrating complete overlap between native 
FG fluorescence and immunofluorescence following incubation of 
sections with anti-FG. 
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The specificity of the PhaL immunolabeling was verified by a 
lack of labeling 1) with omission of the primary antibody; 2) with 
preabsorption of the primary antibody with PhaL; and 3) in tissues that 
had not been injected with PhaL. 
The anti-VGluT2 primary antiserum recognizes a single 65-kDA 
band in brain tissue corresponding to the molecular weight predicted 
for VGluT2, and VGluT2 labeling is lost following omission of the 
primary antiserum or preabsorption of the antiserum with the 
immunizing peptide (Zhou et al., 2007; Graziano et al., 2008). VGluT2 
immunoreactivity was specifically localized in brain regions known to 
receive projections from areas containing dense VGluT2 mRNA 
expression, and the labeling did not correspond with patterns of 
staining seen using antibodies against VGluT1 (Flak et al., 2009). 
Image analysis 
Anatomical regions of interest were defined using the Paxinos 
and Watson (1998) and Swanson (1998) rat brain atlases. Anatomical 
mapping was performed by viewing material under both brightfield and 
darkfield microscopy to define anatomical landmarks, including 1) the 
location and size of the white matter tracts (e.g., fornix, optic tract, 
etc.) and ventricles; 2) variations in cellular density (e.g., compact 
zone of dorsomedial hypothalamic nucleus); and 3) variations in the 
density of VGluT mRNA labeling (e.g., VGluT2 mRNA in the 
ventromedial hypothalamus). For the bed nucleus of the stria 
terminalis, the anterodorsal subdivision refers to the entire portion 
that is dorsal to the crossing of the anterior commissure at that 
rostral-caudal level, whereas the anteroventral subdivision refers to 
the entire portion that is ventral to the crossing of the anterior 
commissure at that rostral-caudal level. Sections were imaged using 
either an Axioplan 2 microscope (Zeiss, Thornwood, NY) equipped with 
an imaging system (Axiocam camera and AxioVision release 4.4 
software; Zeiss) or an AxioImager.Z1 microscope (Zeiss) equipped 
with apotome (z-stack) imaging capability (Axiocam MRm camera and 
AxioVision Release 4.6 software; Zeiss). 
Cell counts were performed for the identified anatomical regions 
at all rostral-caudal levels as they appeared in the evenly spaced, 1-in-
6 series of tissue sections. The reported cell counts were not corrected 
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for sampling interval. Since the FG injection sites included different 
proportions of the PVN, the location of the retrogradely labeled 
neurons varied across the individual cases. In addition, retrogradely 
labeled cells varied widely in size, shape, and distribution, making it 
impossible to generate valid estimates of the mean cell diameter. 
Hence, uncorrected raw profile counts for individual animals are given, 
without an attempt to correct them for cell size. We recognize that the 
larger cells will be somewhat overrepresented in these samples. 
Criterion for identification of FG-immunoreactive cells was a clearly 
visible DAB reaction product in the shape of a neuronal cell body, often 
including neuronal processes. Dual-labeled cells were defined as FG-
immunoreactive cells overlain by grain densities 5 times that of an 
equivalent background area (i.e., an adjacent region containing fiber 
tracts). The number of cells positive for FG only (DAB-positive) and 
those doublepositive for FG and VGluT mRNA were counted throughout 
forebrain. Subsequent analyses focused on brain regions that 
consistently contained at least 10 FG-positive cells from either the 
anterior PVN, posterior PVN, or both, reasoning that these brain 
regions likely represent the primary sources of significant 
glutamatergic innervation to the PVN and its surround. For the PhaL 
anterograde analysis, dual fluorescence immunolabeling was imaged 
throughout the rostral-caudal extent of the PVN via apotome z-stack 
images (each optical section of z-stack had a thickness of ≈0.45µm) 
and the relative prevalence of dual-labeled boutons was noted. For 
clarity of presentation (Figs. 1, ,2,2, ,44–6), image contrast and 
brightness were adjusted using Adobe Photoshop 7.0 (San Jose, CA). 
In addition, the dodge and burn tools in Adobe Photoshop 7.0 were 
used in some of the low-magnification brightfield images (Figs. 4–6) to 
correct for uneven illumination. 
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Figure 1 FG-injection sites into the PVN and its surround showed varying 
involvement along the rostral-to-caudal extent of the nucleus. The anterior-to-mid 
portions of the PVN were primarily involved in cases 90 (≈bregma −1.4 mm for left 
and middle; ≈bregma −1.8 mm for right), 110 (≈bregma −1.3 mm for left and 
middle; ≈bregma −1.8 mm for right), and 112 (≈bregma −1.4 mm for left and 
middle; ≈bregma −1.8 mm for right), whereas the mid-to-posterior portions of the 
PVN were primarily involved in cases 102 (≈bregma −2.12 mm for left and middle; 
≈bregma −1.8 mm for right), 104 (≈bregma −2.12 mm for left and middle; ≈bregma 
−1.8 mm for right), and 109 (≈bregma −2.12 mm for left and middle; ≈bregma −1.8 
mm for right). Injection sites were imaged using brightfield microscopy (left) and were 
mapped onto schematics (middle and right) modified from the Paxinos and Watson 
atlas (1998), following immunolabeling for FG with DAB visualization. Scale bars = 
200 µ.m. 
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Figure 2 Representative examples of cellular labeling for FG and vescicular 
glutamate transporter mRNA. A: Two FG-positive cells in the medial preoptic area; no 
other DAB labeling in the image reached criterion for quantification as an FG-positive 
neuron (asterisk). B: Focusing on the silver grains (black dots) that overlie the cells in 
panel A shows that one FG-positive cell is also positive for VGluT1 mRNA (arrow), 
whereas the other is not (arrowhead). Cells that colabeled for FG and VGluT1 mRNA 
were rarely observed in any of the examined brain regions. C: Two FG-positive cells in 
the ventromedial hypothalamic nucleus; no other DAB labeling in the image reached 
criterion for quantification as an FG-positive neuron (asterisk). D: Focusing on the 
silver grains (black dots) that overlie the cells in panel C shows that one FG-positive 
cell is also positive for VGluT2 mRNA (arrow), whereas the other is not (arrowhead). 
Also note that the background leve of hybridization was higher for VGluT1, so more 
silver grains (5× background) were required for a cell to be considered VGluT1-
positive. Scale bars = 20 µm. 
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Figure 4 PhaL injections into the ventromedial hypothalamic nucleus produced 
more anterogradely labeled fibers in the anterior than posterior PVN. A: Diagram (left) 
and brightfield image (right) depicting the location of a PhaL injection site in the 
ventromedial nucleus (case 15; ≈bregma −2.8 mm). B: Brightfield image shows 
numerous PhaL-positive fibers and boutons in the anterior PVN (≈bregma −0.8 mm) 
and its surround. C: At the level of mid PVN (≈bregma −1.8 mm), few PhaL fibers and 
boutons are seen in the parvocellular subdivision with even less in the magnocellular 
subdivision; some PhaL-positive fibers occur in the PVN surround. D: In the posterior 
PVN (≈bregma −2.1 mm), there are few PhaL-positive fibers and boutons in the 
medial portion and even fewer in the lateral portion, with numerous PhaL-positive 
fibers occurring ventrally in the PVN surround (i.e., sub-PVN). Dual immunolabeling for 
PhaL (green) and VGluT2 (magenta) shows a greater density of PhaL-positive fibers 
and boutons in anterior (E) versus posterior (F) PVN, with relatively comparable levels 
of VGluT2 labeling (images are projections made from z-stack images). In the anterior 
PVN, higher magnification views of a single optical section (≈0.45 µm thick) show a 
PhaL-positive bouton (arrow; G) that is also positive for VGluT2 (arrow; H,I; dual 
labeling appears white). In the posterior PVN, higher magnification views of a single 
optical section (≈0.45 µm thick) show three PhaL-positive boutons (arrows; J) that are 
also positive for VGluT2 (arrows; K,L). Diagram in (A) modified from Paxinos and 
Watson (1998). Scale bars = 200 µm for A–D; 20 µm for E,F; 5 µm for G–I; 10 µm for 
J–L. 
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Figure 6 PhaL injections into the medial preoptic hypothalamic nucleus produced 
more anterogradely labeled fibers in the anterior than posterior PVN. A: Diagram (left) 
and brightfield image (right) depicting the location of a PhaL injection site in the 
medial preoptic nucleus (case 20; ≈bregma −0.8 mm). B: Brightfield image shows 
numerous PhaL-positive fibers and boutons in the anterior PVN (≈bregma −0.8 mm) 
and its surround. C: At the level of mid PVN (≈bregma −1.8 mm), few PhaL fibers and 
boutons are seen in the parvocellular subdivision with even less in the magnocellular 
subdivision; some PhaL-positive fibers occur in the PVN surround. D: In the posterior 
PVN (≈bregma −2.1 mm), there are few PhaL-positive fibers and boutons in the 
medial portion and even fewer in the lateral portion, with some PhaL-positive fibers 
occurring in the PVN surround. Dual immunolabeling for PhaL (green) and VGluT2 
(magenta) shows a greater density of PhaL-positive fibers and boutons in anterior (E) 
versus posterior (F) PVN, with relatively comparable levels of VGluT2 labeling (images 
are projections made from z-stack images). In the anterior PVN, higher magnification 
views of a single optical section (≈0.48 µm thick) show a PhaL-positive bouton (G) 
that is not positive for VGluT2 (H,I). In the posterior PVN, higher magnification views 
of a single optical section (≈0.41 µm thick) show a PhaL-positive bouton (J) that is not 
positive for VGluT2 (K,L); dual labeled boutons were not observed in either the 
anterior or posterior PVN. Diagram in (A) modified from Paxinos and Watson (1998). 
Scale bars = 200 µm for A–D; 10 µm for E,F; 5 µm for G–L. 
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Results 
FG injection sites and forebrain retrograde labeling 
There were six cases in which the FG injection involved the PVN 
with minimal spread into adjacent structures; these cases varied in the 
degree of rostral-to-caudal involvement of the PVN (Fig. 1). The FG 
injection in case 90 included most of the anterior PVN (e.g., bregma 
−1.4 mm) with a small amount in the dorsal-most portion of the PVN 
at more caudal levels. Adjacent structures that contained some FG 
included the peri-PVN, nucleus reuniens, and medial tip of the zona 
incerta. In case 110 the FG injection site filled the anterior PVN (e.g., 
bregma − 1.0 and −1.4 mm) and hit the dorsal edge of the PVN at 
mid-PVN levels (e.g., bregma −1.8 mm). This case had minimal FG 
spread into the peri-PVN and nucleus reuniens. In case 112 the FG site 
involved almost the entirety of the PVN at anterior (e.g., bregma −1.3 
mm) and mid-PVN levels (e.g., bregma −1.7 mm). There was little FG 
spread into the peri-PVN and medial preoptic area/ nucleus. The FG 
injection site in case 102 included much of the posterior PVN (bregma 
−2.1 mm) and hit the dorsal edge of the PVN at mid-PVN levels (e.g., 
bregma −1.8 mm), as well as small amounts into the peri-PVN, 
anterior hypothalamic nucleus posterior subdivision, and medial tip of 
the zona incerta. The FG injection site in case 104 included much of 
the posterior PVN (bregma −2.1 mm) and hit the dorsal edge of the 
PVN at mid-PVN levels (e.g., bregma −1.8 mm), with small amounts 
into the nucleus reuniens and the medial tip of the zona incerta. In 
case 109 the FG site involved the medial portion of the PVN at mid- 
(bregma −1.8 mm) and posterior- (bregma −2.1 mm) PVN levels with 
some FG spread into the contralateral medial PVN, the nucleus 
reuniens, and the medial tip of the zona incerta. An initial analysis 
indicated that in several forebrain regions the number of retrogradely 
labeled FG cells varied with the rostral-to-caudal extent of the FG 
injection site in the PVN. Therefore, subsequent analyses were 
conducted by dividing the cases into two groups: those that involved 
the anterior-to-mid PVN (cases 90, 110, and 112) and those that 
involved the mid-to-posterior PVN (cases 102, 104, and 109), with 
mid-PVN being defined as approximately bregma −1.8 mm, using the 
Paxinos and Watson coordinate system (1998). 
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Forebrain regions that contained substantial numbers of 
retrogradely labeled FG-positive cells (on average >10 from anterior 
and/or posterior PVN) are listed in Table 2, and include regions in the 
bed nucleus of the stria terminalis, hypothalamus, and thalamus. It 
should be noted that in addition to the cell counts presented on Table 
2, a few FG-positive cells (on average <5 per region) were 
occasionally observed in the nucleus of the diagonal band and 
subregions of the amygdala (e.g., central and cortical), thalamus (e.g., 
reticular, and parataenial) and hypothalamus (e.g., anterodorsal 
preoptic nucleus, anteroventral preoptic nucleus, supraoptic nucleus, 
and the anterior part of the ventromedial nucleus; for abbreviations, 
see Table 3), but the low incidence in these regions precluded further 
quantification of VGluT colocalization. Low numbers of FG-positive cells 
were commonly observed in the subfornical area and organum 
vasculosum of the lamina terminalis and many of these appeared to be 
VGluT2-positive; however, the low prevalence precluded further 
quantification. Similarly, low numbers of FG-positive cells were 
occasionally observed in the anterior PVN following FG injections 
targeted to the posterior PVN but the low prevalence precluded 
quantification. 
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VGluT1 and VGluT2 mRNA expression 
Robust expression of VGluT1 mRNA was observed in the 
cerebral cortex, hippocampus, medial habenula, and lateral amygdala, 
as previously noted (Ziegler et al., 2002). Weaker VGluT1 mRNA 
hybridization signal (diffuse labeling) was observed in hypothalamic 
nuclei, including the PVN and supraoptic nucleus. Only a few double-
labeled FG/VGluT1-positive neurons (Fig. 2) were observed in the 
forebrain, and the frequency of these neurons was too low to permit 
quantification. 
VGluT2 mRNA was highly expressed in the habenula (medial and 
lateral), thalamus, and hypothalamus, including the ventromedial 
hypothalamic nucleus, anteroventral periventricular nucleus, preoptic 
nuclei, dorsomedial hypothalamic nucleus, posterior hypothalamic 
nucleus, lateral hypothalamic area, and mammillary nuclei, as noted 
previously (Ziegler et al., 2002). More moderate expression of VGluT2 
mRNA was noted in portions of the medial amygdala, substantia 
innominata, bed nucleus of the stria terminalis, zona incerta, anterior 
hypothalamic nucleus, tuberal nucleus, and retrochiasmatic area, often 
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limited to scattered cells. By comparison, the PVN and supraoptic 
nucleus expressed low levels of VGluT2 mRNA (diffuse labeling lacking 
cellular resolution). Numerous double-labeled FG/VGluT2-positive 
neurons (Fig. 2) were observed throughout forebrain, with some 
notable variations depending on the rostral-to-caudal extent of the FG 
injection site in the PVN. Therefore, subsequent results are presented 
divided into two groups: FG injection sites in anterior-to-mid PVN 
versus in mid-to-posterior PVN. 
VGlut2-innervation to anterior PVN 
Following FG injection in the anterior PVN and its surround 
(Table 2; Fig. 3), high numbers of FG-positive cell bodies were 
observed ipsilaterally in the anterior hypothalamic area and nucleus, 
lateral hypothalamic area, medial preoptic area and nucleus, 
ventromedial hypothalamic nucleus, medial amygdala, and zona 
incerta. Among these regions, only the ventromedial hypothalamic 
nucleus represented a primary source of VGluT2-positive innervation, 
with ≈25% of the FG-labeled cells colabeling for VGluT2. 
 
Figure 3 FG injections into the anterior versus posterior PVN and its surround 
reveal differing extents of VGluT2 mRNA colocalization in PVN-projecting brain regions. 
Case 110 (anterior-to-mid PVN injection) is shown on the left side of the brain 
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illustrations (open circles denote cells that are positive for FG only, whereas filled 
circles denote cells that are dual positive for FG and VGluT2 mRNA). Case 102 
(posterior-to-mid PVN injection) is shown on the right side of the brain illustrations 
(open triangles denote cells that are positive for FG only, whereas filled triangles 
denote cells that are dual positive for FG and VGluT2 mRNA). A: ≈Bregma −0.4 mm. 
B: ≈Bregma −0.5 mm. C: ≈Bregma −1.55 mm. D: ≈Bregma −1.8 mm. E: ≈Bregma 
−2.8 mm. F: ≈Bregma −3.3 mm. Approximate cell locations were mapped onto 
schematics modified from the Swanson atlas (1998). 
More moderate numbers of FG-positive cell bodies were found 
ipsilaterally in the bed nucleus of the stria terminals (anterodorsal, 
anteroventral, interfascicular/ventral, and principle subdivisions), 
arcuate nucleus, dorsomedial hypothalamic nucleus, lateral preoptic 
area, median preoptic area, posterior hypothalamic nucleus, 
periventricular hypothalamic nucleus, retrochiasmatic area, 
suprachiasmatic nucleus, tuberal nucleus, paraventricular thalamic 
nucleus, lateral septum, and substantia innominata after injection in 
the anterior PVN and its surround. These regions generally contributed 
little-to-no VGluT2-positive innervation to the anterior PVN and its 
surround (less than 15% colocalization). 
Contralateral to the FG injection site (data not shown), the 
pattern of FG-positive cell labeling was generally similar to that 
observed ipsilaterally; however, the total number of FG-positive cells 
in each region was substantially lower. Moreover, FG coexpression with 
VGluT2 was low throughout contralateral forebrain (less than 15%). 
VGlut2-innervation to posterior PVN 
FG injection into the posterior PVN and its surround (Table 2; 
Fig. 3) produced high numbers of FG-positive cell bodies in the 
anterior hypothalamic nucleus, lateral hypothalamic nucleus, posterior 
hypothalamic nucleus, ventromedial hypothalamic nucleus, lateral 
septum, and zona incerta. Of these regions, the ventromedial 
hypothalamic nucleus and posterior hypothalamic nucleus were major 
sources of VGluT2 innervation to the posterior PVN, with ≈80% and 
60% colocalization, respectively. The anterior hypothalamic nucleus 
and lateral hypothalamic area also contributed VGluT2 innervation, 
with ≈25% colocalization. In contrast, the lateral septum and zona 
incerta contributed little-to-no VGluT2 innervation to the posterior PVN 
and its surround (less than 5% colocalization). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
The Journal of Comparative Neurology, Vol. 519, No. 7 (May 2011): pg. 1301-1319. DOI. This article is © Wiley and 
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission 
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
20 
 
More moderate numbers of FG-positive cells were consistently 
located in the bed nucleus of the stria terminalis (anteroventral and 
interfascicular/ventral subdivisions), dorsomedial hypothalamic 
nucleus, lateral preoptic area, medial preoptic area and nucleus, 
paraventricular thalamic nucleus, medial amygdala, and substantia 
innominata following FG injection into the posterior PVN and its 
surround. Among these regions a large proportion of the FG-positive 
cells coexpressed VGluT2 in the paraventricular thalamic nucleus 
(≈80%), medial amygdala (≈50%), and dorsomedial hypothalamic 
nucleus (≈40%). Significantly fewer FG-positive cells colabeled for 
VGluT2 in the bed nucleus of the stria terminalis, lateral preoptic area, 
medial preoptic area and nucleus, and substantia innominata 
(generally no more than 15% colocalization). 
Contralateral to the FG injection site (data not shown), the 
pattern of FG-positive cell labeling was generally similar to that 
observed ipsilaterally; however, the total number of FG-positive cells 
in each region was reduced. Moreover, FG coexpression with VGluT2 
was still high in the contralateral ventromedial hypothalamic nucleus 
(≈80%), paraventricular thalamic nucleus (80%), and posterior 
hypothalamus (≈70%); moderate in the anterior hypothalamic nucleus 
(25%), lateral hypothalamic area (25%), medial amygdala (35%), and 
dorsomedial hypothalamic nucleus (40%); and low in the bed nucleus 
of the stria terminalis, lateral preoptic area, medial preoptic area and 
nucleus, lateral septum, substantia innominata, and zona incerta 
(generally less than 15%). 
Anterograde PhaL labeling from ventromedial nucleus 
to PVN 
Three cases (11, 13, and 15) contained PhaL injection sites in 
the ventromedial nucleus. In case 11 the PhaL site involved the 
dorsomedial subdivision, central subdivision, and the dorsal portion of 
the ventrolateral subdivision, with only minimal spread dorsally into 
the dorsomedial hypothalamic nucleus. The PhaL injection site in case 
13 included the lateral portions of the dorsomedial and central 
subdivision and the dorsal portion of the ventrolateral subdivision, with 
minimal lateral spread into the lateral hypothalamic area. The PhaL 
injection site in case 15 included the dorsomedial subdivision, the 
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medial portion of the central subdivision, and the mediodorsal portion 
of the ventrolateral subdivision, with minimal spread beyond the 
ventromedial nucleus. The PhaL labeling produced in the PVN was 
similar for all three cases; representative images from cases 13 and 15 
are shown in Figure 4. The anterior PVN contained numerous PhaL-
positive fibers and boutons throughout the nucleus. The posterior PVN 
showed few PhaL-positive fibers and the mid-PVN contained an 
intermediate amount; at theses levels PhaL-positive fibers and boutons 
were present only in the medial (e.g., parvocellular) portions of the 
nucleus. Dual immunolabeling for PhaL and VGluT2 showed that while 
the posterior PVN contains a relatively small number of PhaL-positive 
boutons, most colabel with VGluT2 immunoreactivity (Fig. 4F,J,K,L). In 
contrast, the anterior PVN receives a richer innervation of PhaL-
positive fibers and boutons, and while several colabel for VGluT2 there 
are also numerous PhaL fibers with boutons that do not colabel, 
suggesting other neurotransmitter phenotypes (Fig. 4E,G–I). 
Anterograde PhaL labeling from posterior hypothalamic 
nucleus to PVN 
Two cases (8 and 10) contained PhaL injection sites targeted to 
the posterior hypothalamic nucleus. The PhaL injection site in case 8 
was located in the dorsal portion of the posterior nucleus with minimal 
spread beyond the nucleus. In case 10 the PhaL injection site was 
similarly located but with a bit of spread dorsal to the nucleus. The 
PhaL labeling produced in the PVN was similar for both cases; 
representative images from case 8 are shown in Figure 5. The anterior 
PVN (≈bregma −0.8 mm) contained few PhaL-positive fibers and 
boutons, whereas mid PVN (≈bregma −1.8 mm) contained several 
PhaL-positive fibers and boutons, particularly in the parvocellular 
subdivision. In the posterior PVN (≈bregma −2.1 mm) there were 
numerous PhaL-positive fibers and boutons throughout the PVN. 
Moreover, PhaL-positive fibers were most dense in the PVN surround 
at the mid and posterior levels. Boutons dual-labeled for PhaL and 
VGluT2 were rarely observed in the anterior PVN, but commonly 
observed in the posterior PVN. 
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Figure 5 PhaL injections into the posterior hypothalamic nucleus produced more 
anterogradely labeled fibers in the posterior than anterior PVN. A: Diagram (left) and 
brightfield image (right) depicting the location of a PhaL injection site in the posterior 
nucleus (case 8; ≈bregma −3.8 mm). B: Brightfield image shows few PhaL-positive 
fibers and boutons in the anterior PVN (≈bregma −0.8 mm). C: At the evel of mid PVN 
(≈bregma −1.8 mm), many PhaL fibers and boutons are seen in the parvocellular 
subdivision with less in the magnocelular subdivision; the greatest density of PhaL-
positive fibers occurs in the PVN surround. D: In the posterior PVN (≈bregma −2.1 
mm), there are numerous PhaL-positive fibers and boutons throughout the PVN and an 
even greater fiber density in the PVN surround. Dual immunolabeling for PhaL (green) 
and VGluT2 (magenta) shows a lower density of PhaL-positive fibers and boutons in 
anterior (E) versus posterior (F) PVN, with relatively comparable levels of VGluT2 
labeling (images are projections made from z-stack images). In the anterior PVN, 
higher magnification views of a single optical section (≈0.45 µ.m thick) show a rare 
PhaL-positive bouton (arrow; G) that is also positive for VGluT2 (arrow; H,I). In the 
posterior PVN, higher magnification views of a single optical section (≈0.45 µm thick) 
show two PhaLpositive boutons (arrows; J) that are also positive for VGluT2 (arrows; 
K,L; dual labeling appears white); dual-labeled boutons are much more commonly 
observed in the posterior versus anterior PVN. Diagram in (A) modified from Paxinos 
and Watson (1998). Scale bars = 200 µm for A–D; 20 µm for E,F; 5 µm for G–L. 
Anterograde PhaL labeling from medial preoptic 
hypothalamic nucleus to PVN 
Two cases (18 and 20) contained PhaL injection sites targeted 
to the medial preoptic hypothalamic nucleus. The PhaL injection site in 
case 18 was located in the rostral portion of the medial preoptic 
nucleus, with minimal spread beyond the nucleus. In case 20 the PhaL 
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injection site included the lateral subdivision, central subdivision, and 
lateral portion of the medial subdivision, with minimal spread into the 
lateral hypothalamic area. The PhaL labeling produced in the PVN was 
similar for both cases; representative images from case 20 are shown 
in Figure 6. The anterior PVN (≈bregma −0.8 mm) contained 
numerous PhaL-positive fibers and boutons, with even higher levels in 
the PVN surround. Mid and posterior PVN had few PhaL fibers in the 
medial portions of the nucleus, with even less in the lateral PVN. 
Notably, boutons dual labeled for PhaL and VGluT2 were not observed 
in the PVN regardless of rostral-caudal level. 
Discussion 
Sources of forebrain glutamatergic innervation to the PVN and 
its surround were determined by combining retrograde FG labeling 
from the PVN with in situ hybridization for VGluT1 and VGluT2 mRNA. 
VGluT1 mRNA was highly expressed in cerebral cortex, hippocampus, 
habenula, and cortical amygdala, with considerably less expression in 
hypothalamic regions, as described previously (Kaneko and Fujiyama, 
2002; Ziegler et al., 2002; Collin et al., 2003). Dual labeling with FG 
revealed only occasional double-labeled cells throughout the 
hypothalamus, with no double-labeling being observed in other 
forebrain sites. These data show that VGluT1-positive neurons do not 
constitute major sources of direct glutamatergic innervation to the 
PVN, as suggested by the presence of few VGluT1-positive nerve fibers 
in the PVN (Wittmann et al., 2005). These data also support the idea 
that forebrain regions containing VGluT1-positive neurons (e.g., 
hippocampus and cerebral cortex) provide information to the PVN via 
indirect circuits that utilize at least one intervening synapse (Herman 
et al., 2003). In contrast, VGluT2 mRNA was highly expressed in the 
habenula, as well as in numerous hypothalamic and thalamic nuclei, as 
described previously (Ziegler et al., 2002; Lin et al., 2003; Hur and 
Zaborszky, 2005; Barroso-Chinea et al., 2007). Dual labeling with FG 
showed many double-labeled neurons throughout the forebrain, 
particularly in the ventromedial hypothalamic nucleus, posterior 
hypothalamic nucleus, lateral hypothalamic area, anterior 
hypothalamic nucleus, dorsomedial hypothalamic nucleus, 
paraventricular thalamic nucleus, and medial amygdala. These data 
demonstrate that VGluT2-positive neurons contribute direct 
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glutamatergic innervation to the PVN and its surround, and originate in 
hypothalamic, thalamic, and amygdalar brain regions. This work is 
consistent with earlier light and electron microscopy studies showing 
that the PVN contains numerous VGluT2-positive nerve fibers that 
contact corticotropin-releasing hormone and thyrotropin-releasing 
hormone neurons (Wittmann et al., 2005; Ziegler et al., 2005), and 
autoradiographic visualization of [3H]D-aspartate transport identifies 
many of the same brain regions as potential sources of 
glutamatergic/aspartatergic innervation to the PVN (Csaki et al., 
2000). Importantly, the proportion of FG labeled neurons that 
colabeled for VGluT2 mRNA varied with the rostral-to-caudal extent of 
the FG injection site within the PVN. When FG injections were targeted 
to the anterior PVN, colocalization with VGluT2 was most common in 
the ventromedial hypothalamic nucleus (≈25% of neurons). However, 
when FG injections were targeted to the posterior PVN, colocalization 
with VGluT2 was most common in the ventromedial hypothalamic 
nucleus (≈80% of neurons), paraventricular thalamic nucleus (≈80%), 
posterior hypothalamic nucleus (≈60%), medial amygdala (≈50%), 
dorsomedial hypothalamic nucleus (≈40%), anterior hypothalamic 
nucleus (≈25%), and lateral hypothalamic area (≈25%). Moreover, 
anterograde PhaL tract tracing combined with VGluT2 immunolabeling 
showed that 1) ventromedial nucleus-derived glutamatergic inputs 
occur in both the anterior and posterior PVN; 2) posterior nucleus-
derived glutamatergic inputs occur predominantly in the posterior 
PVN; and 3) medial preoptic nucleus-derived inputs to the PVN are not 
glutamatergic, thereby independently corroborating the innervation 
pattern. These data suggest that the extent of PVN innervation by 
VGluT2-positive neurons varies between the anterior and posterior 
portions of the nucleus and may have important implications for PVN 
regulation (discussed further below). 
In the present work, FG labeling from the PVN and its surround 
identified numerous forebrain sites that contained PVN/surround-
projecting neurons (Table 2). This pattern of retrograde labeling from 
the PVN mirrors that reported by others (Berk and Finkelstein, 1981; 
Tribollet and Dreifuss, 1981; Sawchenko and Swanson, 1983; 
Campeau and Watson, 2000), including the observation that 
retrograde labeling in the medial amygdala is greater after injections 
into the anterior PVN (Sawchenko and Swanson, 1983). In addition, 
the PVN/surround-projecting forebrain regions identified in the present 
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study are consistent with anterograde labeling studies. For instance, 
the present data using PhaL tract tracing from the ventromedial, 
posterior, and medial preoptic hypothalamic nuclei, taken together 
with prior anterograde tract-tracing studies, demonstrate that the 
anterior hypothalamic area and nucleus, dorsomedial hypothalamic 
nucleus, lateral hypothalamic area, medial preoptic area and nucleus, 
posterior hypothalamic nucleus, ventromedial hypothalamic nucleus, 
paraventricular thalamic nucleus, medial amygdala, lateral septum, 
substantia innominata, and zona incerta project fibers into the PVN 
(Chiba and Murata, 1985; ter Horst and Luiten, 1986, 1987; Grove, 
1988; Simerly and Swanson, 1988; Canteras et al., 1994; Risold et 
al., 1994; Canteras et al., 1995; Vertes et al., 1995; Wagner et al., 
1995; Thompson et al., 1996; Risold and Swanson, 1997; Prewitt and 
Herman, 1998) and/or peri-PVN regions (Ter Horst and Luiten, 1987; 
Simerly and Swanson, 1988; Canteras et al., 1994, 1995; Risold et al., 
1994; Moga et al., 1995; Vertes et al., 1995; Risold and Swanson, 
1997). Of note, a more limited number of FG-positive neurons were 
observed in numerous other forebrain sites, including the subfornical 
area and organum vasculosum of the lamina terminalis, which are 
known to provide direct input to the PVN (Swanson and Lind, 1986; 
Larsen and Mikkelsen, 1995; Duan et al., 2008; Shi et al., 2008). In 
these particular regions the number of FG-positive cells was too low to 
permit quantification of VGluT2 colocalization, possibly because the 
relatively small size of these structures leads to infrequent sampling, 
thereby providing fewer opportunities to visualize the cells. However, 
we did observe several FG-positive cells in these regions that were 
also positive for VGluT2 mRNA, suggesting that at least some of the 
direct PVN projections from the subfornical organ and organum 
vasculosum of the lamina terminalis are glutamatergic (Antunes et al., 
2006). 
Moreover, the present study assessed potential differential 
weighting of forebrain inputs to the anterior versus posterior portions 
of the PVN. Following FG injections targeted to the anterior PVN, more 
FG neurons were seen in the anterior hypothalamic area and nucleus 
(central subdivision), arcuate nucleus, bed nucleus of the stria 
terminalis, medial amygdala, median preoptic area, medial preoptic 
area and nucleus, retrochiasmatic area, reticular thalamic nucleus, 
suprachiasmatic nucleus, tuberal nucleus, and ventromedial 
hypothalamic nucleus than with FG targeting to the posterior PVN, 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
The Journal of Comparative Neurology, Vol. 519, No. 7 (May 2011): pg. 1301-1319. DOI. This article is © Wiley and 
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission 
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
26 
 
suggesting that these forebrain sites may provide relatively greater 
inputs to the anterior (versus posterior) PVN. Anterograde PhaL tract 
tracing from the ventromedial hypothalamic nucleus (Fig. 4), medial 
preoptic nucleus (Fig. 6), and ventral medial amygdala (data not 
shown) corroborates this idea, in that a higher density of PhaL fibers 
derived from these structures were observed in the anterior versus 
posterior PVN. In addition, others have shown that anterograde 
labeling from the central subdivision of the anterior hypothalamic 
nucleus (Risold et al., 1994), anterodorsal preoptic nucleus (Thompson 
and Swanson, 2003), anteroventral preoptic nucleus (Thompson and 
Swanson, 2003), medial preoptic nucleus (Thompson and Swanson, 
2003), retrochiasmatic area (Ribeiro-Barbosa et al., 1999), ventral 
medial amygdala (Prewitt and Herman, 1998), and ventromedial 
hypothalamic nucleus (Canteras et al., 1994) yields more fibers in the 
rostral versus caudal PVN, consistent with the retrograde labeling 
observed presently. In contrast, similar numbers of FG neurons were 
seen in the lateral hypothalamic area following anterior and posterior 
PVN injections, suggesting that the extent of lateral hypothalamic area 
input does not vary over the rostral-to-caudal extent of the nucleus. 
Following FG targeted to the posterior PVN, larger numbers of FG 
neurons were observed in the dorsomedial hypothalamic nucleus, 
lateral preoptic area, lateral septum, posterior hypothalamic nucleus, 
paraventricular thalamic nucleus, substantia innominata, and zona 
incerta relative to anterior PVN injections, suggesting that the 
posterior PVN and its surround may receive greater forebrain inputs 
from these regions. Anterograde PhaL tract tracing from the posterior 
hypothalamic nucleus (Fig. 5) revealed greater numbers of PhaL-
positive fibers and boutons in the posterior (versus anterior) PVN, 
supporting this pattern of innervation. However, anterograde labeling 
from the lateral septum (data not shown) confirmed innervation 
primarily of the PVN surround, with little entering the PVN itself (Risold 
and Swanson, 1997), regardless of rostral-caudal level. FG-positive 
neurons in the lateral septum following injection targeted to the PVN 
probably resulted from the unavoidable spread of small amounts of FG 
into the immediate vicinity of the PVN. For example, the lateral septum 
projects to the reuniens nucleus of the thalamus, the zona incerta, and 
the peri-PVN (Risold and Swanson, 1997). The spread of FG likely 
occurred to a larger extent for the posterior PVN, where the shape of 
the nucleus becomes laterally elongated such that the circular-shaped 
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FG injection inevitably spreads further beyond the dorsal and/or 
ventral boundaries of the nucleus. Notably, the collective innervation 
pattern of the PVN seems to generally follow a spatial map, with 
anterior and mid-level hypothalamic regions (anterior hypothalamic 
area/nucleus, arcuate, median preoptic, medial preoptic, 
retrochiasmatic, suprachiasmatic, tuberal, and ventromedial nuclei) 
being identified as providing innervation preferentially to anterior-mid 
PVN, and with mid-level and posterior hypothalamic regions 
(dorsomedial and posterior nuclei) being identified as providing 
innervation preferentially to mid-posterior PVN. 
Anterograde labeling from the ventromedial, posterior, and 
medial preoptic hypothalamic nuclei was combined with VGluT2 
immunolabeling to determine 1) whether any observed colabeling of 
FG and VGluT2 mRNA in these sites originated from the PVN itself 
versus its immediate surround; and 2) whether the density of PVN 
glutamatergic innervation from these sites varied across the rostral-to-
caudal extent of the nucleus. Ventromedial nucleus-derived PhaL fibers 
and boutons were present throughout the PVN, with the highest 
density occurring in the anterior portion of the nucleus. Colabeling of 
these PhaL fibers with VGluT2 immunoreactivity often occurred in the 
PVN regardless of rostral-caudal level, suggesting that the 
ventromedial nucleus is a source of PVN glutamatergic innervation 
across the entire rostral-caudal extent of the nucleus. In contrast, 
posterior hypothalamic nucleus-derived PhaL fibers and boutons 
occurred with greatest frequency in the posterior PVN, as did colabeled 
boutons for VGluT2 immunoreactivity, suggesting that the posterior 
nucleus contributes glutamatergic innervation predominantly to the 
posterior PVN. Medial preoptic nucleus-derived PhaL fibers and 
boutons were most prevalent in the anterior PVN; however, colabeling 
with VGluT2 was not observed regardless of rostral-caudal level, 
suggesting that the medial preoptic nucleus uses other 
neurotransmitters (e.g., GABA) and does not contribute glutamatergic 
innervation to the PVN. Additional anterograde labeling studies will be 
needed to confirm differential glutamatergic innervation of the PVN by 
the other implicated forebrain regions. However, the collective work 
supports the contention that glutamatergic innervation of the anterior-
to-mid PVN and its surround is largely derived from the ventromedial 
hypothalamic nucleus, whereas glutamatergic innervation of the mid-
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to-posterior PVN and its surround originates primarily in the 
ventromedial, lateral, posterior, and dorsomedial hypothalamic nuclei. 
Methodological considerations 
The irregular geometries of the anterior and posterior PVN 
present a significant barrier to retrograde tract-tracing studies. In the 
current report we endeavored to interpret our data with respect to 
both the present and previous anterograde tracing studies. 
Nonetheless, we need to acknowledge that VGlut2 innervation of the 
PVN proper (versus the PVN-surround) may be overestimated by the 
retrograde labeling approach. 
Immunohistochemical analyses of VGluT1 and VGluT2 
immunoreactivity indicate nearly exclusive localization in terminals 
(Herzog et al., 2001; Lin et al., 2003). This staining pattern prohibits 
use of dual immunohistochemistry for colocalization of VGluT1 or 
VGluT2 immunoreactivity in FG-positive neuronal cell bodies. The 
double-labeling approach used here provides a reliable and proven 
colocalization method for immunoreactivity and mRNA. However, 
visualization of colocalization requires imaging silver grains in a thin 
emulsion layer atop a 30 µm section (see Fig. 2 for example). We have 
taken a conservative approach to identifying FG-positive neurons and 
confirming mRNA colocalization, and may be missing colocalization in 
FG-positive cells that are relatively deep within the tissue section or 
whose morphology did not clearly resemble a cell body. In addition, 
the fact that radioactive grains lie in an emulsion layer above cellular 
sources probably causes us to miss radioactive sources lying deep in 
the section. Thus, the current report likely under-estimates the 
number of VGluT2/FG colocalized cells. Alternatively, it is possible that 
VGluT mRNA expression is not a universal marker for glutamatergic 
neurons. Previous studies establish VGluT1 and VGluT2 mRNA as 
specific markers of the glutamatergic neurons (reviewed in Ziegler et 
al., 2002; Takamori, 2006), but it is not yet known if they are 
expressed in all glutamate neurons. Since our approach was consistent 
across animals, the overall proportion of colocalized cells in a given 
region can be compared between animals and injection sites. 
Anterograde tract tracing with PhaL is a well-established 
approach that labels the efferent projections from injection sites. PhaL 
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injection sites are relatively small, providing increased anatomical 
specificity at the expense of labeling the full extent of projecting 
neurons. Thus, the abundance of PhaL-positive labeling in the PVN 
following injection in the ventromedial, posterior, and medial preoptic 
hypothalamic nuclei reflects labeling of only a subset of neurons in 
these areas. Importantly, PhaL labels both the projecting fibers and 
their terminals/boutons, providing the ability to coimmunolabel for 
VGluT2 (which localizes only to glutamatergic nerve terminals). In this 
manner, the proportion of PhaL-positive terminals that colabel with 
VGluT2 can be visualized. However, since PhaL also labels projecting 
fibers (versus VGluT2 immunoreactivity, which is only detected in 
terminals), quantifying the relative amount of PhaL labeling that is 
dual-labeled for VGluT2 cannot provide a meaningful representation of 
the amount of PhaL-positive terminals that are colabeled. Hence, the 
most appropriate manner to view this material is to gauge the relative 
proportion of PhaL-positive terminals (excluding the fibers) that are 
colabeled for VGluT2. 
We should note that we have not included VGluT3 in our 
analyses, as the present literature does not support it as a major 
source of forebrain glutamatergic input to the PVN (Gras et al., 2002; 
Schafer et al., 2002; Herzog et al., 2004). VGluT3 mRNA is present in 
rodent brain at levels much below that of VGluT1 and VGluT2, and with 
a much more limited forebrain distribution (e.g., scattered cells of 
striatum, hippocampus, and neocortex) (Gras et al., 2002; Schafer et 
al., 2002; Herzog et al., 2004). Moreover, VGluT3 mRNA expression 
appears to largely occur in interneurons and/or brain regions that are 
known to have little-to-no direct projections to the PVN (Gras et al., 
2002; Schafer et al., 2002; Herzog et al., 2004), thus the present 
work focuses on VGluT1 and VGluT2 as the primary potential sources 
of forebrain glutamatergic input to the PVN. 
Functional considerations 
An important consideration of the present work is the relative 
abundance (and hence functional importance) of glutamatergic 
innervation to the PVN. Clearly some sources of innervation (e.g., 
posterior hypothalamic nucleus, Fig. 5) provide a denser innervation to 
the PVN-surround than to the PVN itself. The PVN surround contains 
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neurons that project into the PVN and regulate its function (Herman et 
al., 2002), thereby providing an indirect means for PVN regulation by 
the posterior hypothalamic nucleus. Additionally, the posterior 
hypothalamic nucleus provides a more modest direct innervation to the 
PVN itself, particularly to the middle and posterior portions. Given the 
preponderance of multiple types of glutamate receptors throughout 
the PVN, including the presence of NMDA-type receptors that function 
to dramatically amplify glutamatergic signaling (Herman et al., 2000), 
even a relatively modest number of glutamatergic inputs could 
contribute significantly to neuronal signaling and PVN function. 
Moreover, the methods employed invariably underestimate the full 
extent of glutamatergic inputs (see Methodological considerations, 
above), suggesting that the most appropriate interpretations are not 
from the actual percentage of colabeling reported, but rather from 
comparing the relative abundance among the various injection sites 
(e.g., anterior versus posterior FG injection sites). Finally, the PVN 
proper has a considerable neuronal density, whereas the surround is 
rich in fibers. Thus, the relative amount of fiber input into the PVN 
proper will likely appear lower than the surround, due to the space 
occupied by the relatively large neuronal somata and their dendrites. 
The observed rostral-to-caudal variations in the innervation of 
the PVN and its surround may have important functional implications. 
The PVN is comprised of connectionally distinct subregions, which vary 
in position and orientation over the rostral-caudal extent of the 
nucleus (reviewed in Sawchenko and Swanson, 1983). For example, 
the anterior-to-middle portion of the PVN is enriched in thyrotropin-
releasing hormone neurons (e.g., anterior, medial, and periventricular 
parvocellular divisions; Lechan and Segerson, 1989), whereas the 
middle-to-posterior PVN contains relatively larger amounts of 
preautonomic neurons (Sawchenko and Swanson, 1983). Moreover, 
the anterior magnocellular PVN primarily contains oxytocinergic 
neurons, whereas the posterior PVN contains both oxytocinergic and 
vasopressinergic magnocellular neurons (Sawchenko and Swanson, 
1983). Based on this, one might predict that PVN functions mediated 
by glutamatergic regulation of the anterior PVN are influenced largely 
by the ventromedial hypothalamic nucleus, whereas functions 
mediated by glutamatergic regulation of the posterior PVN are 
predominantly influenced by the ventromedial hypothalamic nucleus, 
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lateral hypothalamic area, posterior hypothalamic nucleus, and 
dorsomedial hypothalamic nucleus. 
In general, the anterior PVN region is lacking a significant 
VGluT2 innervation from forebrain structures, with the exception of the 
ventromedial hypothalamus. Regions projecting into the anterior PVN 
are generally rich in GABAergic and peptidergic neurons (cf. Harlan et 
al., 1987; Simerly and Swanson, 1987; Okamura et al., 1990), 
suggesting that forebrain regulation of this region may be 
accomplished primarily by these nonglutamatergic neuronal inputs. 
The fact that the ventromedial nucleus is the primary source of 
forebrain glutamate anterior PVN input is intriguing, given its role in 
satiety mechanisms and glucose regulation (King, 2006). The anterior-
to-mid PVN is enriched in neuroendocrine TRH cells that are implicated 
in metabolic regulation (Lechan and Fekete, 2006), suggesting the 
potential for glutamate-mediated activation of thyroid hormone 
release. It is also important to consider that the anterior PVN contains 
non-neuroendocrine neurons that innervate the lateral septum as well 
as brainstem sites (Swanson and Kuypers, 1980; Risold and Swanson, 
1997), providing an opportunity for metabolic information to be 
communicated to limbic regulators of body temperature and brainstem 
mediators of energy regulation. 
The posterior PVN has by far the largest population of 
preautonomic (i.e., brainstem and spinal cord) projecting neurons in 
the nucleus (Sawchenko and Swanson, 1983). The more extensive 
network of posterior PVN region-projecting VGlut2 neuron suggests a 
prominent role of forebrain (particularly hypothalamic) glutamate in 
autonomic functions of the PVN, which include regulation of heart rate, 
blood pressure, and sympathetic nerve discharge (Badoer et al., 2003; 
Kenney et al., 2003; Li et al., 2006; Freeman and Brooks, 2007). The 
present data suggest a greater capacity for direct excitation of this 
region by glutamate, consistent with rapid relay of homeostatic input 
to autonomic effector systems. 
The distribution of CRH neurons in the PVN straddles the 
anterior and posterior divisions (Swanson et al., 1987). These data 
suggest that the forebrain sources of input to CRH neurons may vary 
across along the rostrocaudal extent of the nucleus, with the anterior 
cell groups receiving VGluT2 innervation largely limited to the 
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ventromedial hypothalamus, and the posterior regions receiving 
significant input from a number of forebrain sources. Possible 
rostrocaudal differences in input to CRH cell groups may reflect the 
composite role of CRH in energy balance and stress regulation. 
Overall, the anterior–posterior differences in innervation 
patterns suggest that the relative role of forebrain glutamate 
projections is differentially distributed with respect to endogenous PVN 
cell populations. The data suggest a selective role for forebrain 
glutamate in control of PVN output and, thereby, homeostatic 
integration. 
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